Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Drakaki

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
BMJ Case Reports|October 6, 2017
Anti-PD-L1 therapy and the onset of diabetes mellitus with positive pancreatic autoantibodiesJennifer Way, Alexandra Drakaki, Andrew Drexler, et al.
Clinics and Practice|January 8, 2019
Rapidly progressive neurologic decline and morbilliform rash presenting in a patient with lymphomaDean Ehrlich, Jennifer Phan, Gavin Hui, et al.
Life (Basel, Switzerland)|March 25, 2022
Treatment Equity in the Immunotherapy Era: Options for Patients with Both Autoimmune Disease and GU CancersGavin Hui, Claire Drolen, Christopher A Hannigan, et al.
European Urology|February 14, 2018
Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After NephrectomyAmirali Salmasi, Izak Faiena, Alexandra Drakaki, et al.
European Urology|February 14, 2018
Re: Abiraterone for Prostate Cancer Not Previously Treated with Hormone TherapyIzak Faiena, Amirali Salmasi, Allan J Pantuck, et al.
Cureus|September 22, 2025
Unchecked Immunity to Unleashed Anarchy: A Case of Hemophagocytic Lymphohistiocytosis Following Combination Immune Checkpoint Inhibitor TherapySunil R Dommaraju, Dimitrios Stefanoudakis, Gavin Hui, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Conceptual Framework for Therapeutic Development Beyond Anti-PD-1/PD-L1 in Urothelial CancerPetros Grivas, Alexandra Drakaki, Terence W Friedlander, et al.
Transplantation Proceedings|October 20, 2019
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Metastatic Cancer Post Solid Organ Transplantation: A Case Report and Review of the LiteratureKarlton Wong, John Shen, Sarah D'Ambruoso, et al.
Life (Basel, Switzerland)|January 21, 2022
Immunotherapy and Metastatic Renal Cell Carcinoma: A Review of New Treatment ApproachesNikhita Kathuria-Prakash, Claire Drolen, Christopher A Hannigan, et al.
The American Journal of Medicine|July 29, 2018
Not Just Another InfectionBingnan Zhang, Aashini K Master, Claire E Brown, et al.
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
BMJ Case Reports|October 6, 2017
Anti-PD-L1 therapy and the onset of diabetes mellitus with positive pancreatic autoantibodiesJennifer Way, Alexandra Drakaki, Andrew Drexler, et al.
Clinics and Practice|January 8, 2019
Rapidly progressive neurologic decline and morbilliform rash presenting in a patient with lymphomaDean Ehrlich, Jennifer Phan, Gavin Hui, et al.
Life (Basel, Switzerland)|March 25, 2022
Treatment Equity in the Immunotherapy Era: Options for Patients with Both Autoimmune Disease and GU CancersGavin Hui, Claire Drolen, Christopher A Hannigan, et al.
European Urology|February 14, 2018
Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After NephrectomyAmirali Salmasi, Izak Faiena, Alexandra Drakaki, et al.
European Urology|February 14, 2018
Re: Abiraterone for Prostate Cancer Not Previously Treated with Hormone TherapyIzak Faiena, Amirali Salmasi, Allan J Pantuck, et al.
Cureus|September 22, 2025
Unchecked Immunity to Unleashed Anarchy: A Case of Hemophagocytic Lymphohistiocytosis Following Combination Immune Checkpoint Inhibitor TherapySunil R Dommaraju, Dimitrios Stefanoudakis, Gavin Hui, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Conceptual Framework for Therapeutic Development Beyond Anti-PD-1/PD-L1 in Urothelial CancerPetros Grivas, Alexandra Drakaki, Terence W Friedlander, et al.
Transplantation Proceedings|October 20, 2019
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Metastatic Cancer Post Solid Organ Transplantation: A Case Report and Review of the LiteratureKarlton Wong, John Shen, Sarah D'Ambruoso, et al.
Life (Basel, Switzerland)|January 21, 2022
Immunotherapy and Metastatic Renal Cell Carcinoma: A Review of New Treatment ApproachesNikhita Kathuria-Prakash, Claire Drolen, Christopher A Hannigan, et al.
The American Journal of Medicine|July 29, 2018
Not Just Another InfectionBingnan Zhang, Aashini K Master, Claire E Brown, et al.
Pageof 14